Actively Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Led by Alnylam Pharmaceuticals · Updated on 2026-03-31
1500
Participants Needed
40
Research Sites
509 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to: * Describe epidemiological and clinical characteristics, natural history and real-world clinical management of ATTR amyloidosis patients * Characterize the safety and effectiveness of patisiran and vutrisiran as part of routine clinical practice in the real-world clinical setting * Describe disease emergence/progression in pre-symptomatic carriers of a known disease-causing transthyretin (TTR) variant
CONDITIONS
Official Title
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of ATTR amyloidosis or documented known disease-causing TTR variant for the cohort of pre-symptomatic carriers
- Germany Only: Patients must be treated per the summary of product characteristics (SmPC) for any approved treatment for ATTR amyloidosis
You will not qualify if you...
- Current enrollment in a clinical trial for any investigational agent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 40 locations
1
Clinical Trial Site
La Jolla, California, United States, 92037
Actively Recruiting
2
Clinical Trial Site
Los Angeles, California, United States, 90095
Actively Recruiting
3
Clinical Trial Site
Jacksonville, Florida, United States, 32224
Actively Recruiting
4
Clinical Trial Site
Iowa City, Iowa, United States, 52242
Actively Recruiting
5
Clinical Trial Site
Kansas City, Kansas, United States, 66160
Actively Recruiting
6
Clinical Trial Site
Baltimore, Maryland, United States, 21224
Actively Recruiting
7
Clinical Trial Site
Boston, Massachusetts, United States, 02127
Completed
8
Clinical Trial Site
New York, New York, United States, 10034
Actively Recruiting
9
Clinical Trial Site
Durham, North Carolina, United States, 27710
Actively Recruiting
10
Clinical Trial Site
Columbus, Ohio, United States, 43210
Actively Recruiting
11
Clinical Trial Site
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
12
Clinical Trial Site
Austin, Texas, United States, 78756
Actively Recruiting
13
Clinical Trial Site
Houston, Texas, United States, 77030
Actively Recruiting
14
Clinical Trial Site
Salvador, Brazil
Actively Recruiting
15
Clinical Trial Site
São Paulo, Brazil
Actively Recruiting
16
Clinical Trial Site
Sofia, Bulgaria
Actively Recruiting
17
Clinical Trial Site
Aarhus, Denmark
Actively Recruiting
18
Clinical Trial Site
Copenhagen, Denmark
Completed
19
Clinical Trial Site
Bordeaux, France
Actively Recruiting
20
Clinical Trial Site
Bron, France
Actively Recruiting
21
Clinical Trial Site
Créteil, France
Actively Recruiting
22
Clinical Trial Site
Le Kremlin-Bicêtre, France
Actively Recruiting
23
Clinical Trial Site
Marseille, France
Actively Recruiting
24
Clinical Trial Site
Berlin, Germany
Actively Recruiting
25
Clinical Trial Site
Giessen, Germany
Actively Recruiting
26
Clinical Trial Site
Hanover, Germany
Actively Recruiting
27
Clinical Trial Site
Jerusalem, Israel
Actively Recruiting
28
Clinical Trial Site
Ramat Gan, Israel
Actively Recruiting
29
Clinical Trial Site
Milan, Italy
Actively Recruiting
30
Clinical Trial Site
Naples, Italy
Actively Recruiting
31
Clinical Trial Site
Palermo, Italy
Actively Recruiting
32
Clinical Trial Site
Roma, Italy
Actively Recruiting
33
Clinical Trial Site
Groningen, Netherlands
Actively Recruiting
34
Clinical Trial Site
Lisbon, Portugal
Actively Recruiting
35
Clinical Trial Site
Porto, Portugal
Actively Recruiting
36
Clinical Trial Site
Barcelona, Spain
Actively Recruiting
37
Clinical Trial Site
Madrid, Spain
Actively Recruiting
38
Clinical Trial Site
Palma, Spain
Actively Recruiting
39
Clinical Trial Site
New Taipei City, Taiwan
Actively Recruiting
40
Clinical Trial Site
Taipei, Taiwan
Actively Recruiting
Research Team
A
Alnylam Clinical Trial Information Line
CONTACT
A
Alnylam Clinical Trial Information Line
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here